SPDR S&P Biotech ETF (XBI) Price, Holdings, & News

ETF Overview

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Key Stats

• Today's Range: $91.88 to $93.86
• 50-Day Range: $86.66 to $94.76
• 52-Week Range: $81.14 to $105.47
• Volume: 2.21 million shs
• Average Volume: 8.89 million shs
• Market Capitalization: $7.03 billion
• Assets Under Management: $6.13 billion
• Dividend Yield: 0.02%
• Net Expense Ratio: 0.35%
• Aggregate Rating: Moderate Buy

XBI ETF - Frequently Asked Questions

How have XBI shares performed this year?

SPDR S&P Biotech ETF's stock was trading at $90.06 at the beginning of 2025. Since then, XBI stock has increased by 2.5% and is now trading at $92.2740.
View the best growth stocks for 2025 here.

Who are SPDR S&P Biotech ETF's major shareholders?

SPDR S&P Biotech ETF's top institutional shareholders include JPMorgan Chase & Co., Jane Street Group LLC, Demars Financial Group LLC (4.08%) and Twin Tree Management LP.

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Biotech ETF investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), iShares Micro-Cap ETF (IWC), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and Humana (HUM).

Fund Details

• Issuer: SSgA
• Fund Name: SPDR S&P Biotech ETF
• Tax Classification: Regulated Investment Company
• Stock Exchange: NYSEARCA
• Current Symbol: NYSEARCA:XBI
• Inception Date: 1/31/2006
• Fund Manager: Michael Feehily, Karl Schneider, Raymond Donofrio
• Web: www.spdrs.com
• Phone: +1-866-7872257

Fund Focus

• Asset Class: Equity
• Benchmark: S&P Biotech Index
• Category: Sector
• Focus: Health Care
• Development Level: Developed Markets
• Region: North America
• Number of Holdings: 164

Fund Statistics

• Assets Under Management: $6.13 billion
• Average Daily Volume: $8.98 million
• Discount/Premium: 0.01%

Administrator, Advisor and Custodian

• Administrator: SSgA Funds Management, Inc.
• Advisor: SSgA Funds Management, Inc.
• Custodian: State Street Bank and Trust Company
• Distributor: State Street Global Advisors Funds Distributors, LLC
• Transfer Agent: State Street Bank and Trust Company
• Trustee: N/A
• Lead Market Maker: Virtu Financial

Options

• Optionable: Optionable
• Options Volume: 34,941
• Put Options: 26,675
• Call Options: 8,266
• Short Interest: 56,140,000 shs

Miscellaneous

• Outstanding Shares: 76,220,000
• Beta: 1.11
• Creation Unit: 50,000
• Creation Fee: $250.00